New inhaler combo may cut rescue treatments in hospitalized COPD patients
NCT ID NCT05292053
First seen Nov 21, 2025 · Last updated May 06, 2026 · Updated 23 times
Summary
This study looked at whether a once-daily inhaler (TRELEGY ELLIPTA) can reduce the need for extra breathing treatments in adults hospitalized for COPD flare-ups. About 80 participants took the inhaler plus short-term steroids and were followed for 30 days after leaving the hospital. The goal was to see if this approach could shorten hospital stays and lower readmission rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott & White Health Research Institute
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.